From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Widecells – a total bargepole with a death spiral on steroids: SELL, SELL, SELL!!

By Nigel Somerville, the Deputy Sheriff of AIM | Sunday 10 March 2019


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Normally when I see a damaging (to shareholders) death spiral in play it is with reference to company trading on the AIM Casino. We’ve had a few: Tern (TERN), Advanced Oncotherapy (AVO) VAST (VAST) to name just three. But Widecells (WDC) is listed on the main market – well, sort of: it was unleashed onto the Standard List in July 2016. But this death spiral really does take some beating!

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 05:03:12